Truist Securities Reiterates Buy Rating on Boston Scientific Corporation (BSX)
Truist Securities analysts reiterated a Buy rating on Boston Scientific Corporation (NYSE:BSX) on February 05, 2026. Boston Scientific Corporation operates in the Healthcare…
Read more
